|
2025
|
Invention
|
Anti-viral compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptabl... |
|
|
Invention
|
Methods and compositions for targeting pd-l1. The present disclosure related to compounds that ca... |
|
|
Invention
|
Pd-l1 compounds with a bicyclic group. The present disclosure relates to compounds that can be us... |
|
|
Invention
|
Anti-viral compounds.
Provided herein are compounds of Formula (I), or pharmaceutically acceptab... |
|
2024
|
Invention
|
Modulators of thr-beta and methods of use thereof.
Disclosed herein are compounds of Formula I:
... |
|
|
Invention
|
Modulators of thr-beta and methods of use thereof. Disclosed herein are compounds of Formula I: o... |
|
|
Invention
|
Methods and compositions for targeting pd-l1.
The present disclosure related to compounds that c... |
|
|
Invention
|
Short interfering nucleic acid (sina) molecules targeting angptl 3 and angptl 8 and methods of us... |
|
|
Invention
|
Modified short inerfering nucleic acid (sina) molecules and uses thereof. OO-methyl nucleotides a... |
|
|
Invention
|
Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof. Disclosed herein are s... |
|
|
Invention
|
Hepatitis b combination therapies. Provided herein are methods of treating a hepatitis B viral an... |
|
|
Invention
|
Methods and compostitions for targeting pd-l1.
The present disclosure related to compounds that ... |
|
2023
|
Invention
|
Modified short interfering nucleic acid (sina) molecules and uses thereof. Described are short in... |
|
|
Invention
|
Bicyclic compounds.
Provided herein are compounds of Formula (I), or pharmaceutically acceptable... |
|
|
Invention
|
Bicyclic compounds. Provided herein are compounds of Formula (I), or pharmaceutically acceptable ... |
|
|
Invention
|
Pyrrole compounds.
Provided herein are compounds of Formula (I), or pharmaceutically acceptable ... |
|
|
Invention
|
Modified short interfering nucleic acid (sina) molecules and uses thereof. Disclosed herein are s... |
|
|
Invention
|
Pyridazinone and methods of use thereof.
Disclosed herein are methods of modulating the activity... |
|
|
Invention
|
Modified gapmer oligomers and methods of use thereof.
The disclosure includes antisense oligonuc... |
|
|
Invention
|
Modified gapmer oligomers and methods of use thereof. The disclosure includes antisense oligonucl... |
|
2022
|
Invention
|
Splice switch oligonucleotide (sso) molecules for targeting β-catenin and uses thereof. The prese... |
|
|
Invention
|
Short interfering nucleic acid (sina) molecules for targeting β-catenin and uses thereof. The pre... |
|
|
Invention
|
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections. Provided h... |
|
|
Invention
|
Modified short interfering nucleic acid (sina) molecules and uses thereof.
Disclosed herein are ... |
|
|
Invention
|
Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof.
Disclosed herein are ... |
|
2020
|
P/S
|
Oligonucleotides; nucleic acids. Pharmaceutical preparations, namely, antivirals; pharmaceutical ... |
|
2018
|
P/S
|
Product research and development; scientific research and development in the field of pharmaceuti... |
